AI MARKET SCANNING

AnaptysBio, Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +5.22%
MAX GAP RECORD +18.60%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ANAB
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Sep 21, 2026 Earnings Release 2026-09-21 (AFTER CLOSE (16:00))
+0.27%
Mar 03, 2026 Earnings Release 2026-03-03 (AFTER CLOSE)
+6.15%
Nov 04, 2025 Earnings Release 2025-11-04 (AFTER CLOSE)
+12.90%
Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE)
+4.53%
May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE)
+0.70%
Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE)
+18.60%
Nov 05, 2024 Earnings Release 2024-11-05 (AFTER CLOSE)
+11.72%
Aug 05, 2024 Earnings Release 2024-08-05 (AFTER CLOSE)
+3.99%

VOLATILITY & GAP BIAS

AVG GAP MOVE 7.1%
Bullish Gaps (9)
Bearish Gaps (1)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ANAB

EXECUTIONS3 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-09-15 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1262m +0.25%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company's products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗